Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies

Am J Respir Crit Care Med. 2021 Dec 15;204(12):e134-e135. doi: 10.1164/rccm.202101-0073IM.

Authors

Aurélie Le Gal¹, Alexandre Chabrol¹, Anne-Laure Brun², Séverine Fraboulet¹, Louis-Jean Couderc^{1

3

4}, Hélène Salvator^{1

3

4}

Affiliations

¹ Respiratory Diseases Department and.
² Radiological Department, Foch Hospital, Suresnes, France.
³ Faculty of Medicine Versailles Saint-Quentin, University Paris-Saclay, Montigny le Bretonneux, France; and.
⁴ UMR 0892, VIM-Suresnes, Suresnes, France.

PMID: 34129433
DOI: 10.1164/rccm.202101-0073IM

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies / blood*
Autoimmune Diseases / blood
Autoimmune Diseases / diagnostic imaging*
Autoimmune Diseases / immunology
Biomarkers / blood
Fatal Outcome
Granulocyte-Macrophage Colony-Stimulating Factor / immunology*
Humans
Male
Middle Aged
Pulmonary Alveolar Proteinosis / blood
Pulmonary Alveolar Proteinosis / diagnostic imaging*
Pulmonary Alveolar Proteinosis / immunology
Tomography, X-Ray Computed*

Substances

Autoantibodies
Biomarkers
Granulocyte-Macrophage Colony-Stimulating Factor

Supplementary concepts

Pulmonary Alveolar Proteinosis, Acquired